Literature DB >> 3672318

The treatment of perforated diverticulitis by one-stage intracolonic bypass procedure.

B Ravo1, A Mishrick, K Addei, G Castrini, G Pappalardo, E Gross, J M Sackier, C B Wood, R Ger.   

Abstract

The one-stage intracolonic bypass procedure prevents gastrointestinal secretions and fecal content from coming in contact with an anastomotic site without interrupting the intraluminal continuity of the fecal flow from proximal to distal colon. This can be achieved by the intraluminal implantation of a soft, pliable tube above the anastomotic site. Previous clinical and experimental data have indicated that the intracolonic bypass procedure can protect an anastomosis in the presence of maximal colonic loading, gross dehiscences, or fecal peritonitis. This report presents 28 patients with perforated diverticulitis, all of whom were treated by one-stage intracolonic bypass procedures. Ten of the 28 patients had peritonitis, and 18 had pericolic abscesses. Results indicate no deaths and no anastomotic leakages. Three patients (10.7%) had a complicated postoperative course. One patient with fecal peritonitis had prolonged ileus and a pulmonary effusion, and one had a myocardial infarction. Both of these patients responded to medical therapy. Another patient had a wound infection. The hospital stay ranged from 10 to 18 postoperative days. All patients passed the tubes spontaneously 2 to 3 weeks after operation. The one-stage intracolonic bypass procedure can be recommended as a viable alternative to the two- or three-stage procedures commonly used for perforated diverticulitis.

Entities:  

Mesh:

Year:  1987        PMID: 3672318

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  11 in total

1.  Insertion of the Coloshield through a colotomy after completion of a colonic anastomosis.

Authors:  B Ravo; D Reggio; F M Frattaroli
Journal:  Int J Colorectal Dis       Date:  1991-02       Impact factor: 2.571

2.  Experimental study of the efficacy of the endoluminal prosthesis in colonic anastomoses.

Authors:  J Serra; G Capella; J Esquius; R Montañes; X Rius
Journal:  Int J Colorectal Dis       Date:  1992-02       Impact factor: 2.571

3.  Endoluminal prosthesis in protecting high-risk colonic anastomosis: an experimental study.

Authors:  Z Krivokapic; D Stevovic; D Dugalic; I Japundzic; R Colovic
Journal:  Int J Colorectal Dis       Date:  1991-11       Impact factor: 2.571

4.  Management of perforated diverticular disease.

Authors:  A Senapati; C G Marks
Journal:  Ann R Coll Surg Engl       Date:  1995-05       Impact factor: 1.891

5.  Acute localized diverticulitis: optimum management requires accurate staging.

Authors:  R Detry; J Jamez; A Kartheuser; F Zech; R Vanheuverzwijn; P Hoang; P J Kestens
Journal:  Int J Colorectal Dis       Date:  1992-02       Impact factor: 2.571

Review 6.  Can intraluminal devices prevent or reduce colorectal anastomotic leakage: a review.

Authors:  Annelien N Morks; Klaas Havenga; Rutger J Ploeg
Journal:  World J Gastroenterol       Date:  2011-10-28       Impact factor: 5.742

7.  Protection of colorectal anastomosis with an intraluminal bypass device for patients undergoing an elective anterior resection: a pilot study.

Authors:  A Reshef; G Ben-Arie; I Pinsk
Journal:  Tech Coloproctol       Date:  2019-07-05       Impact factor: 3.781

8.  The unopened colostomy: a procedure to protect colonic anastomosis.

Authors:  F Vaxman; C Ionescu; P Volkmar; O Pambou; J F Grenier
Journal:  Int J Colorectal Dis       Date:  1993-03       Impact factor: 2.571

9.  Extraperitoneal manifestation of perforated diverticulitis.

Authors:  J M Rothenbuehler; D Oertli; F Harder
Journal:  Dig Dis Sci       Date:  1993-11       Impact factor: 3.199

10.  Long-term fecal diverting device for the prevention of sepsis in case of colorectal anastomotic leakage: an animal experiment.

Authors:  Jae Hwang Kim; Sang Hun Jung; Yong-Jin Kim; Se-Ll Park; Dae-Hwan Kim
Journal:  Int J Colorectal Dis       Date:  2012-09-30       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.